Alto Neuroscience (ANRO) Financials: Revenue & Earnings

ANRO price $24.00 +0.67 +2.87%

Ticker
ANRO
Price
$24.00
Change
+0.67 +2.87%
Market cap ?
$941.81M
P/E ?
-8.95
Dividend yield ?
0.00%
Beta ?
1.16
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
72
Value
42
Quality
76
Growth
99

Stocklytics score rationale: value 42, quality 76, growth 99.

Financials

20212022202320242025
2100000000

Alto Neuroscience, Inc. operates as a biopharmaceutical entity in the clinical stage, specializing in the creation of novel psychiatric medications. Its development pipeline includes ALTO-100, an investigational therapy targeting individuals affected by major depressive disorder (MDD) and post-traumatic stress disorder. Also in its portfolio is ALTO-300, a small molecule designed to function as both a melatonergic…

Fair value

ANRO fair value Not meaningful. Price $24.00.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ANRO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.67——
2026-08-12-0.65-0.73——
2026-05-13-0.80-0.56——
2026-03-16-0.45-0.56——
2025-11-12-0.52-0.66——
2025-08-13-0.65-0.57——
2025-05-14-0.53-0.59——
2025-03-20-0.56-0.65——
2024-11-12-0.62-0.67——
2024-08-13-0.60-0.71——
2024-05-14-0.76-0.46——
2024-03-21-7.77-1.67——
2024-02-05-0.34———
2023-06-29-0.32———
2023-03-31-0.27———
2022-12-31-0.30———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-02Smith Nicholas ConradBuy55.00K$2.32127.60K
2026-10-02Smith Nicholas ConradSell55.00K$2.32127.60K
2026-09-30Smith Nicholas ConradSell24.06K$2.3556.53K
2026-09-30Smith Nicholas ConradBuy24.06K$2.3556.53K
2026-09-30Smith Nicholas ConradSell23.17K$25.78597.29K
2026-09-30Smith Nicholas ConradSell886$26.8723.81K
2026-09-29Smith Nicholas ConradSell56.45K$2.35132.67K
2026-09-29Smith Nicholas ConradBuy54.38K$2.35127.78K
2026-09-29Smith Nicholas ConradBuy56.45K$2.35132.67K
2026-09-29Smith Nicholas ConradSell54.38K$2.35127.78K
2026-09-29Smith Nicholas ConradSell110.83K$26.582.95M
2026-05-27Miller Andrew CraigBuy26.00K$20.44531.44K
2026-05-27Miller Andrew CraigOther0——
2026-05-14Etkin AmitSell400.00K——
2026-05-12Sanchez RamiroBuy10.96K$24.63269.90K
2026-05-12Cox Christopher NixonBuy10.96K$24.63269.90K
2026-05-12Manji HusseiniBuy10.96K$24.63269.90K
2026-05-12Dreyfus AndrewBuy10.96K$24.63269.90K
2026-05-12York GwillBuy10.96K$24.63269.90K
2026-03-01Etkin AmitSell6.23K$19.69122.61K
2026-03-01Smith Nicholas ConradSell2.81K$19.6955.25K
2026-02-11Etkin AmitBuy306.00K$16.715.11M
2026-02-11Savitz AdamBuy124.00K$16.712.07M
2026-02-11Smith Nicholas ConradBuy200.00K$16.713.34M
2026-02-11Hanley Jr. Michael ConickBuy131.00K$16.712.19M
2026-01-02York GwillBuy5.24K$16.5986.98K
2026-01-02Cox Christopher NixonBuy7.19K$16.59119.27K
2026-01-02Manji HusseiniBuy4.23K$16.5970.14K
2026-01-02Sanchez RamiroBuy3.81K$16.5963.14K
2025-08-12Sanchez RamiroBuy30.57K$3.1897.23K
2025-08-12Sanchez RamiroBuy3.93K$3.1812.49K
2025-08-12Sanchez RamiroOther0——
2025-07-03Hanley Jr. Michael ConickBuy188.00K$2.35441.80K
2025-07-03Hanley Jr. Michael ConickBuy125.00K$2.35293.75K
2025-07-03Hanley Jr. Michael ConickBuy8.00K$2.3518.80K
2025-07-03Hanley Jr. Michael ConickSell188.00K$12.402.33M
2025-07-03Hanley Jr. Michael ConickSell125.00K$4.20525.00K
2025-07-03Hanley Jr. Michael ConickSell8.00K$14.88119.04K
2025-07-03Savitz AdamBuy123.64K$2.35290.57K
2025-07-03Savitz AdamBuy76.00K$2.35178.60K
2025-07-03Savitz AdamBuy73.00K$2.35171.55K
2025-07-03Savitz AdamBuy33.01K$2.3577.57K
2025-07-03Savitz AdamBuy22.48K$2.3552.83K
2025-07-03Savitz AdamSell123.64K$5.30655.32K
2025-07-03Savitz AdamSell33.01K$6.23205.64K
2025-07-03Savitz AdamSell73.00K$14.881.09M
2025-07-03Savitz AdamSell76.00K$4.20319.20K
2025-07-03Etkin AmitBuy247.29K$2.35581.13K
2025-07-03Etkin AmitBuy223.00K$2.35524.05K
2025-07-03Etkin AmitBuy215.00K$2.35505.25K
2025-07-03Etkin AmitBuy34.62K$2.3581.36K
2025-07-03Etkin AmitSell223.00K$14.883.32M
2025-07-03Etkin AmitSell34.62K$6.23215.68K
2025-07-03Etkin AmitSell215.00K$4.20903.00K
2025-07-03Etkin AmitSell247.29K$5.301.31M
2025-07-03Smith Nicholas ConradBuy202.33K$2.35475.47K
2025-07-03Smith Nicholas ConradBuy135.00K$2.35317.25K
2025-07-03Smith Nicholas ConradBuy90.00K$2.35211.50K
2025-07-03Smith Nicholas ConradBuy44.96K$2.35105.66K
2025-07-03Smith Nicholas ConradBuy33.83K$2.3579.51K
2025-07-03Smith Nicholas ConradSell202.33K$5.301.07M
2025-07-03Smith Nicholas ConradSell33.83K$6.23210.78K
2025-07-03Smith Nicholas ConradSell135.00K$4.20567.00K
2025-07-03Smith Nicholas ConradSell90.00K$14.881.34M
2025-05-13Manji HusseiniBuy15.29K$2.3736.23K
2025-05-13Cox Christopher NixonBuy15.29K$2.3736.23K
2025-05-13Dreyfus AndrewBuy15.29K$2.3736.23K
2025-05-13York GwillBuy15.29K$2.3736.23K
2025-02-05Hanley Jr. Michael ConickBuy125.00K$4.20525.00K
2025-02-05Smith Nicholas ConradBuy135.00K$4.20567.00K
2025-02-05Savitz AdamBuy76.00K$4.20319.20K
2025-02-05Etkin AmitBuy215.00K$4.20903.00K
2025-01-02York GwillBuy19.56K$4.3885.66K
2025-01-02Manji HusseiniBuy14.20K$4.3862.17K
2025-01-02Cox Christopher NixonBuy25.24K$4.38110.53K
2024-07-10Savitz AdamBuy2.93K$13.2238.75K
2024-07-09Savitz AdamBuy1.39K$13.1518.25K
2024-07-09Savitz AdamBuy10.68K$12.53133.83K
2024-05-20Hanley Jr. Michael ConickBuy188.00K$12.402.33M
2024-05-20Hanley Jr. Michael ConickOther8.00K$14.88119.04K
2024-03-28Smith Nicholas ConradBuy4.55K$16.5675.35K
2024-03-28Smith Nicholas ConradBuy1.60K$15.8025.28K
2024-03-08Radhakrishnan MahaBuy30.57K$13.76420.70K
2024-03-08Radhakrishnan MahaBuy1.59K$13.7621.88K
2024-03-08Radhakrishnan MahaOther0——
2024-03-01Savitz AdamBuy73.00K$14.881.09M
2024-03-01Etkin AmitBuy34.71K——
2024-03-01Etkin AmitBuy223.00K$14.883.32M
2024-03-01Smith Nicholas ConradBuy90.00K$14.881.34M
2024-03-01Smith Nicholas ConradBuy19.15K——
2024-02-06Apeiron Investment Group Ltd.Buy674.66K——
2024-02-06Apeiron Investment Group Ltd.Buy251.88K——
2024-02-06Apeiron Investment Group Ltd.Sell444.56K——
2024-02-06Apeiron Investment Group Ltd.Sell1.06M——
2024-02-06Apeiron Investment Group Ltd.Sell416.67K——
2024-02-06Alpha Wave Global, LPBuy600.00K$16.009.60M
2024-02-06Alpha Wave Global, LPBuy1.14M——
2024-02-06Alpha Wave Global, LPBuy1.96M——
2024-02-06Alpha Wave Global, LPSell1.96M——
2024-02-06Alpha Wave Global, LPSell1.14M——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 120, holders +6 vs prior quarter. Ownership 69.02%.

HolderSharesChangeChange %Value
ALPHA WAVE GLOBAL, LP3.71M00.00%97.85M
COMMODORE CAPITAL LP2.72M00.00%71.87M
BLACKROCK, INC.2.12M1.45M+218.38%55.97M
PERCEPTIVE ADVISORS LLC1.61M-400.00K-19.90%42.49M
ADAGE CAPITAL PARTNERS GP, L.L.C.1.60M1.22M+315.58%42.22M
VANGUARD CAPITAL MANAGEMENT LLC1.39M182.45K+15.12%36.67M
SPRUCE STREET CAPITAL LP1.35M27.84K+2.10%35.71M
VIVO CAPITAL, LLC1.21M173.31K+16.74%31.90M
FRANKLIN TEMPLETON INC1.01M-88.57K-8.04%26.74M
ARMISTICE CAPITAL, LLC864.00K-48.00K-5.26%22.80M
AFFINITY ASSET ADVISORS, LLC850.00K350.00K+70.00%22.43M
VESTAL POINT CAPITAL, LP785.00K-1.28M-61.97%20.72M
STATE STREET CORP685.95K486.44K+243.83%18.10M
GEODE CAPITAL MANAGEMENT, LLC678.20K385.30K+131.55%17.90M
72 INVESTMENT HOLDINGS, LLC667.78K00.00%17.62M
NORTHERN TRUST CORP632.70K159.30K+33.65%16.70M
MILLENNIUM MANAGEMENT LLC558.32K-263.66K-32.08%14.73M
POINT72 ASSET MANAGEMENT, L.P.502.95K-137-0.03%13.27M
VENROCK ADVISER, LLC500.00K00.00%13.20M
INTEGRAL HEALTH ASSET MANAGEMENT, LLC500.00K00.00%13.20M
DRIEHAUS CAPITAL MANAGEMENT LLC487.58K850+0.17%12.87M
PARKMAN HEALTHCARE PARTNERS LLC429.04K429.04KNew11.32M
IKARIAN CAPITAL, LLC407.34K-107.66K-20.91%10.75M
PRICE T ROWE ASSOCIATES INC /MD/358.28K-12.93K-3.48%9.46M
ORBIMED ADVISORS LLC257.85K90.35K+53.94%6.80M

Earnings and financials

Alto Neuroscience, Inc. (ANRO) trades at $24.00, with a market cap of $941.81M and a trailing P/E of -8.95. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

20212022202320242025
2100000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Alto Neuroscience (ANRO) Financials: Revenue & Earnings

ANRO$24.00+0.67 +2.87%

$941.81M

Market Cap

-8.95

P/E

—

Forward P/E

72

Score

Price History